RETRACTED: The Significance of PAX8-PPARγ Expression in Thyroid Cancer and the Application of a PAX8-PPARγ-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer

Table 2

Correlations of PAX8-PPARγ expression in human thyroid cancer with clinical pathological parameters.

	Number (n)	PAX8-PPARγ overexpression	χ^2	value
Age (years)
<40	36	29	0.64	>0.05
≥40	29	22
Gender
Male	18	14	0.71	>0.05
Female	47	37
Tumour (cm)
<1	12	9	0.48	>0.05
1–4	45	35
>4	8	7
Pathological type
Papillary thyroid carcinoma	31	24	0.56	>0.05
Follicle carcinoma	22	17
Medullary carcinoma	11	9
Undifferentiated carcinoma	1	1
TNM stage
I-II	39	27	6.39	<0.01
III-	26	24
Differentiation grade
I	20	11	7.08	<0.01
II	26	21
III	19	19
Lymph node metastasis
Present	23	22	8.17	<0.01
Absent	42	29
Capsular invasion
Present	20	19	9.25	<0.01
Absent	45	32